FINDING THE IDEAL SEQUENCE IN 3L mCRC – EXPERIENCE FROM DAILY PRACTICE
Prof Mario Scartozzi
Full professor and chairperson,
medical oncology director,
School of nursing,
University of Cagliari, Italy
Prof Timothy Price
Director of medical oncology
and clinical cancer research,
Queen Elizabeth Hospital,
Adelaide, Australia
This webinar focuses on planning the treatment sequence in mCRC and selecting patients to extend the continuum of care. Incorporating FTD/TPI in 3L and considering anti-EGFR rechallenge in 4L showed promises in optimizing outcomes for patients. An interactive clinical patient case is presented throughout the webinar to discuss the ideal treatment sequence.
Key points covered
This webinar introduced ways to select mCRC patients and to sequence treatments in order to optimize patients outcomes.
An interactive clinical patient case was presented to determine the appropriate treatment sequence.
This webinar highlighted the different possibilities in 3L+ therapy choices and that have shown potential in improving patient outcomes in mCRC.
Featured Speakers
Professor Price
Prof Timothy Price is Senior Consultant Medical Oncologist and Director of Medical Oncology and Clinical Cancer Research at The Queen Elizabeth Hospital in Adelaide. His major clinical interest is in treatment of patients with gastrointestinal cancer, and he is currently involved in an extensive gastrointestinal clinical trial program. He is professor at the University of Adelaide and Colorectal Cancer Stream leader for the South Australian Health and Medical Research Institute, and leads the gastrointestinal translational and research laboratory at the Basil Hetzel Institute. He chairs the current national NHMRC Cancer Council Colorectal Guidelines committee which led to the recently published update. He is also a visiting/honorary professor at the University of Sydney and the University of Antwerp.
Professor Scartozzi
Professor Mario Scartozzi is an Italian professor in Medical Oncology specialized in GI cancers. Since 2014, he has been the Head of the Medical Oncology Department and a Full Member of the Academic Commission of the PhD course in Translational Medicine at the University and University Hospital of Cagliari, Italy. Professor Scartozzi is the author or co-author of around 250 medical publications.